Multi-Drug Resistance 1 (MDR1) Mouse Monoclonal Antibody (clone C494), Concentrate - Citations

Multi-Drug Resistance 1 (MDR1) Mouse Monoclonal Antibody (clone C494), Concentrate - Citations

View additional product information for Multi-Drug Resistance 1 (MDR1) Mouse Monoclonal Antibody (clone C494), Concentrate - Citations (187243)

Showing 2 product Citations

Citations & References
Abstract
CDX2 regulates multidrug resistance 1 gene expression in malignant intestinal epithelium.
AuthorsTakakura Y, Hinoi T, Oue N, Sasada T, Kawaguchi Y, Okajima M, Akyol A, Fearon ER, Yasui W, Ohdan H,
JournalCancer Res
PubMed ID20699370
'The caudal-related homeobox transcription factor CDX2 has a key role in intestinal development and differentiation. CDX2 heterozygous mutant mice develop colonic polyps, and loss of CDX2 expression is seen in a subset of colon carcinomas in humans. Ectopic CDX2 expression in the stomach of transgenic mice promotes intestinal metaplasia, and ... More
Immunohistochemical Estimates of Angiogenesis, Proliferative Activity, p53 Expression, and Multiple Drug Resistance Have No Prognostic Impact in Osteosarcoma: A Comparative Clinicopathological Investigation.
AuthorsSorensen FB, Jensen K, Vaeth M, Hager H, Funder AM, Safwat A, Keller J, Christensen M,
JournalSarcoma
PubMed ID19266050
'Purpose. To investigate angiogenesis, multiple drug resistance (MDR) and proliferative activity as prognostic variables in patients suffering from osteosarcoma. Methods. Histologic biopsies from 117 patients treated in the period from 1972 through 1999 were immunohistologically investigated regarding angiogenesis (CD34), proliferative activity (MIB-1), and the expression of p53 and MDR (P-glycoprotein ... More